[2] Tirzepatide, the active ingredient in Mounjaro, is a dual GIP/GLP-1 receptor agonist that mimics two hormones: GLP-1 and GIP, giving it a combined effect on appetite, blood sugar control and fat metabolism
Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB
Some of my patients have hit plateaus, and Im able to make a lot of nuanced adjustments as it pertains to either changing their medication, adjusting the doses, and/or focusing on the details when it comes to dietary changes and exercise programming as well as hormone optimization, she shares
10.4103/0378-6323.186500 26 PickartL.MargolinaA
Patient Characteristics
IN MANY CASES, THE CONSTRAINT IS NO LONGER INNOVATION ITS INDUSTRIALISATION. This concentration of demand is creating a ripple effect across the industry